A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for free
Conservative entrepreneur Vivek RamaswamyScott Olson/Getty PicturesRoche acquired a bowel-disease therapy from Roivant…
Family Of Henrietta Lacks Settles With Biotech Company Accused Of Profiting From Her Cells
BALTIMORE (AP) — Greater than 70 years after docs at Johns Hopkins…
Recursion Pharmaceuticals soars 121% after Nvidia invests $50 million in the biotech for AI drug discovery
The Recursion Prescribed drugs lab in Salt Lake Metropolis, Utah.Recursion MedicineShares of…
